If a person living with HIV has no access to HIV treatment, cotrimoxazole prophylaxis should be taken for the rest of the patient's life. If the patient has access to antiretroviral therapy (ART) for HIV (Study Session 22), cotrimoxazole prophylaxis should be stopped when the CD4 count has increased to 350 cells/mm³ and remains above that level for at least six months. Note that only the healthcare provider at the health centre should stop the cotrimoxazole prophylaxis — you are not expected to stop cotrimoxazole prophylaxis.

Last modified: Saturday, 24 May 2014, 5:55 PM